Revenue segments as reported by the company.

Electronics & Industrial

Water & Protection

Corporate & Other

Mobility & Materials

Corporate

Electronics & Imaging

Nutrition & Biosciences

Transportation & Industrial

Safety & Construction

Non-Core

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development expenses

Selling, general and administrative expenses

Amortization of intangibles

Restructuring and asset related charges - net

Goodwill impairment charges

Acquisition, integration and separation costs

Equity in earnings of nonconsolidated affiliates

Sundry income (expense) - net

Interest expense

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

DuPont de Nemours

Danisco is a Danish bio-based company with activities in food production, enzymes and other bioproducts as well as a wide variety of pharmaceutical grade excipients. It was formed in 1989 from the largest Danish industrial merger ever of the two old C.F. Tietgen companies Danish Sugar (founded 1872), and Dansk Handels- og Industri Company (Danisco A/S).

Danisco

Solae was an international soy ingredients supplier based in St. Louis, Missouri. Solae was formed as a joint venture between DuPont and Bunge Limited. On May 1, 2012, Solae announced that DuPont had acquired Bunge's 28% share, thus taking full ownership of the company. DuPont then merged Solae's business into Danisco. The company developed food, feed and industrial ingredients, focusing on soy. Many of the studies supporting the Food and Drug Administration-approved health claim were based on research using Solae soy protein.

Solae

DuPont de Nemours, Inc. is a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics and Industrial, Water and Protection, and Corporate and Others. The Electronics and Industrial segment involves the supply of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The Water and Protection segment focuses on the provision of engineered products and integrated systems for many industries including worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The company was founded in 1897 and is headquartered in Wilmington, DE.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

DuPont reports strong Q4 results, eyes growth amid challenges

DuPont's Q4 performance showcased organic revenue growth and margin improvement, supported by strategic actions and portfolio transformation.
While facing challenges in the shelter business and market conditions, DuPont remains focused on innovation, growth opportunities, and shareholder value enhancement.
The company's outlook for 2023 includes solid top-line growth, operational targets, and a strategic focus on managing challenges and leveraging growth opportunities.

DuPont exceeds Q1 expectations, eyes healthcare growth amid market challenges

DuPont's Q1 performance was solid, with revenue and adjusted EPS surpassing guidance, driven by acquisitions and ongoing market strengths. Challenges in the electronics market and inventory destocking impacted full-year guidance, but opportunities for growth in healthcare and other sectors are on the horizon. The company's focus on sustainability and operational efficiency remains key.

DuPont reports resilient Q2 performance amidst market challenges

DuPont's Q2 performance showed resilience amid market challenges, with a focus on strategic priorities for long-term growth.
While facing volume pressures and market uncertainties, DuPont is leveraging acquisitions and cost controls to drive value.
Opportunities lie in sequential business improvements, cost reductions, and sustainability-focused sales strategies.
Challenges include market-specific declines and regional growth variations that require strategic adjustments.

DuPont reports solid Q3 earnings amidst China challenges and growth opportunities

DuPont's Q3 performance showcased resilience amid challenges, with revenue declines offset by improved margins and EPS growth. Strategic acquisitions and divestitures are driving the company forward.
Despite facing headwinds in China and inventory destocking, DuPont is capitalizing on opportunities in semiconductors and other key segments. Efforts to enhance efficiency and target growth areas position the company for future success.
While challenges like trade restrictions and industrial destocking persist, DuPont remains focused on leveraging growth opportunities in AI, electronics, and other segments. Maintaining a strong cash position and returning value to shareholders are key priorities.

DuPont reports Q4 2023 results, eyes growth in key markets

DuPont's Q4 performance saw declines in net sales and EBITDA, but the company remains resilient amidst market challenges. Cost-saving initiatives and share repurchase programs demonstrate strategic financial management.
Despite absorption headwinds and challenges in China, DuPont's focus on key markets like semiconductors and water positions it for growth. The company's long-term EBITDA margin outlook is positive.
Opportunities in market stabilization, recovery in key sectors, and potential growth in water and electronics segments offer DuPont avenues for future expansion and profitability.

DuPont surpasses Q1 expectations, eyes growth amid market challenges

DuPont's Q1 2024 performance exceeded expectations, prompting an upward revision of full-year guidance across key financial metrics.
The company's focus on operational excellence, sustainability, and market diversification positions it well for recovery and growth in 2024 and beyond.
While facing challenges in pricing and market dynamics, DuPont's strategic initiatives and opportunities in key segments offer avenues for future growth.
Overall, DuPont's strong performance, prudent risk management, and focus on innovation and efficiency underscore its resilience and potential for sustained success.

DuPont surpasses Q2 expectations, eyes growth in tech and China

DuPont delivered strong Q2 2024 results, exceeding guidance and showcasing resilience across key segments.
Strategic initiatives like the Donatelle acquisition and planned separation activities position DuPont for future growth and market leadership.
While legal challenges persist, DuPont's proactive approach and focus on innovation and diversification bode well for long-term success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Anthem

Bausch Health Companies Inc

Norfolk Southern

Takeda Pharmaceutical

Tenet Healthcare

Glenview Capital Management recently disclosed its portfolio updates for the fourth quarter of 2020, which ended on Dec. 31.

The Top New Buys of Larry Robbins' Firm

On 2/26/21, DuPont will trade ex-dividend, for its quarterly dividend of $0.30, payable on 3/15/21.

Cash Dividend On The Way From DuPont

Citigroup

Cigna

Deere & Company

Home Depot

Procter & Gamble

Visa

Micron Technology

When it comes to picking blue-chip stocks from the S&P 500, it's not just dividends that matter, and some names are being overlooked. The post 7 Blue-Chip Stocks to Buy Investors Are Overlooking appeared first on InvestorPlace.

7 Blue-Chip Stocks to Buy Investors Are Overlooking

WILMINGTON, Del., Feb. 18, 2021 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a first quarter dividend of $0.30 per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable March 15, 2021, to holders of record of...

DuPont Declares Regular Quarterly Dividend on Common Stock

“Mining” has become synonymous with crypto the past few years in the tech industry, what with Bitcoin piercing the $50,000 barrier and GPUs and ASICs worldwide scrambling to hash functions in a bid for distributed crypto manna. That excitement belies an increasingly energetic push though to bring VC dollars and entrepreneurial acumen back to Mining […]

DuPont and VCs see lithium mining as a critical investment for the electric future

Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

Use DuPont Analysis to Pick 5 Top-Ranked Quality Stocks

The stock price of DuPont de Nemours Inc. has seen a 9% decline over the last five trading days, while it is down 13% over the last ten trading days, and we believe the stock will likely rebound from the current levels in the near term.

Can DuPont Stock Rebound After A 13% Drop In 10 Days?

DuPont de Nemours, Inc. (DD) CEO Edward Breen on Q4 2020 Results - Earnings Call Transcript

DuPont (DD) saw strong demand in semiconductors and smartphones technologies and sustained recovery in the automotive market in Q4.

DuPont's (DD) Earnings and Revenues Surpass Estimates in Q4

Shares of DuPont de Nemours (NYSE:DD) moved higher by 0.7% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were unchanged 0.00% over the past year to $0.95, which beat the estimate of $0.89.

Recap: DuPont Q4 Earnings

Shares of DuPont de Nemours Inc. were indicated up nearly 1% in premarket trading Tuesday, after the materials and chemicals company reported fourth-quarter profit and sales that beat Wall Street expectations, as strength in semiconductors and smartphone technologies, and further recovery in automotive markets, offset weakness in oil and gas, aerospace and certain industrial markets. Net income rose to $222 million, or 30 cents a share, from $176 million, or 24 cents a share, in the year-ago period.

DuPont's stock set to rise after profit, sales beat expectations

WILMINGTON, Del., Feb. 9, 2021 /PRNewswire/ -- DuPont (NYSE: DD) today announced financial results for the fourth quarter 2020. "The leading positions we hold in automotive, protective garments, residential construction, semiconductor, and smartphones markets enabled us to capitalize on...

DuPont Reports Fourth Quarter 2020 Results

Avient Corp

Celanese

Dow Inc

Eastman Chemical

W. R. Grace & Co.

A rebound in demand in major markets and benefits of self-help actions are likely to have aided the performance of chemical companies in Q4. Let's see how DD, FMC, GRA and AVNT are poised ahead of their earnings releases.

Chemical Stock Earnings to Watch on Feb 9: DD, FMC & More

Corteva Inc

Farmland Partners

IDEXX Laboratories

Gladstone Land

Starboard Value Acquisition Corp.

Zoetis

Investing in Agriculture Stocks: What Investors Need to Know

WILMINGTON, Del., Feb. 3, 2021 /PRNewswire/ -- DuPont (NYSE: DD) announced today the final results of its exchange offer, and the final proration factor of 52.5307455 percent, in connection with the previously announced separation of its nutrition and biosciences business (the "N&B...

DuPont Announces Final Results of Exchange Offer in Connection with IFF Transaction

Why you should depend on the DuPont technique to pick solid profit-generating stocks.

Depend on DuPont to Buy 5 Top-Ranked Healthy Stocks

NEW YORK and WILMINGTON, Del. and CHICAGO and RIYADH, Saudi Arabia, Feb. 1, 2021 /PRNewswire/ -- An international private equity consortium consisting of BroadPeak Global LP ("BroadPeak Global"), Asia Green Fund ("AGF") and The Saudi Arabian Industrial Investments Company ("Dussur")...

International Private Equity Consortium to Buy DuPont Clean Technologies

WILMINGTON, Del., Feb. 1, 2021 /PRNewswire/ -- DuPont (NYSE:DD) announced it is completing today the merger of IFF and Nutrition & Biosciences. In connection with the closing of the transaction with IFF, DuPont receives a special cash payment of about $7.3 billion, approximately $5...

DuPont Positioned as Premier Multi-industrial Company, Equipped for Growth and Value Creation, following Completion of IFF and Nutrition & Biosciences Merger

WILMINGTON, Del., Feb. 1, 2021 /PRNewswire/ -- DuPont (NYSE: DD) announced today the preliminary results of its exchange offer in connection with the previously announced separation of its nutrition and biosciences business (the "N&B Business") and merger of Nutrition & Biosciences, Inc....

DuPont Announces Preliminary Results of Exchange Offer in Connection with IFF Transaction

Air Products and Chemicals

Ecolab

Fidelity MSCI Materials Index ETF

iShares U.S. Basic Materials ETF

New Linde PLC

Newmont Mining

Vanguard Materials ETF

Materials Select Sector SPDR Fund

Let's delve into the earnings picture of the companies that would drive the performance of materials ETFs as these dominate their portfolio.

What's in Store for Material ETFs in Q4 Earnings?

WILMINGTON, Del., Jan. 27, 2021 /PRNewswire/ -- DuPont (NYSE: DD) announced today that the final exchange ratio for its exchange offer will be 0.7180 shares of common stock of Nutrition & Biosciences, Inc. ("N&B") for each share of DuPont common stock that is validly tendered and not...

DuPont Sets Final Exchange Ratio of 0.7180 in Split-Off Exchange Offer in Connection with IFF Transaction

DuPont de Nemours (DD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can DuPont de Nemours (DD) Keep the Earnings Surprise Streak Alive?

WILMINGTON, Del., Jan. 26, 2021 /PRNewswire/ -- On December 31, 2020, DuPont (NYSE:DD) commenced its exchange offer (the "Exchange Offer")1 whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. ("N&B") common...

DuPont Exchange Offer to Expire January 29, 2021

Chemours

DuPont de Nemours Inc. , Corteva Inc. and Chemours Co. announced Friday an agreement to settle legal disputes, and to establish a cost-sharing arrangement related to PFAS liabilities. Under terms of the agreement, expenses will be split 50-50, with DuPont and Corteva responsible for one half and Chemours responsible for the other half.

DuPont, Corteva and Chemours settle PFAS legal disputes, with expenses capped at $4 billion

WILMINGTON, Del., Jan. 22, 2021 /PRNewswire/ -- DuPont de Nemours, Inc. (NYSE: DD), Corteva, Inc. (NYSE: CTVA) and The Chemours Company (NYSE: CC) today announced they have entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating...

News for DuPont de Nemours Stock (DD)